Notice of Proposed Sale · 144
Denali Therapeutics Inc.
DNLINASDAQEQUITYCurrent
Notice of Proposed Sale
Structured filing — 144
primary_doc.xml
Notice of proposed sale. The proposed amounts below do not establish that a sale occurred.
Proposed-sale notice
- Issuer
- Denali Therapeutics Inc.
- Issuer CIK
- 0001714899
- SEC file number
- 001-38311
- Phone
- (650)866-8547
- Person for whose account securities are to be sold
- NANCY THORNBERRY
- Relationships to issuer
- Director
- Street
- 161 Oyster Point Blvd.
- City
- South San Francisco
- State / country code
- CA
- Postal code
- 94080
Securities proposed for sale
| Security | Proposed units | Aggregate market value | Units outstanding | Approximate sale date | Exchange | Broker / market maker |
|---|---|---|---|---|---|---|
| Common | 11,439 | 266,128.34 | 159,847,403 | 09/02/2026 | NASDAQ | Morgan Stanley Smith Barney LLC Executive Financial Services |
Broker / market maker — proposed row 1, entry 1
- Name
- Morgan Stanley Smith Barney LLC Executive Financial Services
- Street
- 1 New York Plaza
- Street (continued)
- 8th Floor
- City
- New York
- State / country code
- NY
- Postal code
- 10004
Acquisition of securities to be sold
| Security | Acquired | Nature of acquisition | Acquired from | Amount acquired | Gift transaction | Payment date | Nature of payment |
|---|---|---|---|---|---|---|---|
| Common | 01/08/2024 | Restricted Stock Units | Issuer | 11,439 | N | 01/08/2024 | N/A |
Prior-sale reporting
- Nothing to report for the preceding three months
- Y
Remarks
The securities to be sold were acquired upon the vesting of restricted stock units during the period of 01/08/2024 through 05/31/2025.
Notice signature
- Notice date
- 09/02/2026
- Signed
- /s/ Nancy Thornberry
- Plan adoption dates
- 06/03/2026